Eris Lifesciences Limited has informed the Exchange about Schedule of meet
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences has informed stock exchanges about an upcoming group meeting with institutional investors scheduled for Monday, May 26, 2025. The interaction will be held in-person with an investor group. The company clarified that only publicly available information will be discussed during the meeting, and no unpublished price sensitive information (UPSI) will be shared. An unedited audio/video recording of the meeting will be kept at the registered office for regulatory inspection if needed.
This is a routine regulatory disclosure and is typically neutral for the stock. It shows the company is actively engaging with investors, which is a positive governance signal, though no new business or financial information is expected from the meeting.